Results from genetically engineered mouse models (GEMMs) of lung cancer, pancreatic cancer and melanoma induced by mutations in RAS or BRAF indicated that autophagy inhibited the growth of early benign tumors, but accelerated the growth of advanced cancers (22–26). This evidence concerns the gene BRAF and lung carcinoma.